Severe muscular weakness: An unusual adverse effect of azathioprine therapy

Journal of Clinical Gastroenterology

Volumn 40, Issue 7, 2006, Pages 626-628

  Karhadkar, Arati S ^a   Schwartz, Howard J ^a,b   Arora, Manish ^a   Dutta, Sudhir K ^a,b,c  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

^b Northwest Hospital   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Hypersensitivity; Inflammatory bowel disease; Myasthenia

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; MESALAZINE; PREDNISONE;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CROHN DISEASE; CUSHINGOID SYNDROME; ENTERITIS; FEVER; HUMAN; HYPERSENSITIVITY REACTION; MALE; MUSCLE WEAKNESS; MYOPATHY; MYOSITIS; PRIORITY JOURNAL; RHABDOMYOLYSIS; SEPSIS; ULCERATIVE COLITIS;

ADULT; AZATHIOPRINE; COLITIS, ULCERATIVE; CROHN DISEASE; DRUG HYPERSENSITIVITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MUSCLE WEAKNESS;

EID: 33747507280     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200608000-00013     Document Type: Article

References (23)

1. Su CG, Stein RB, Lewis JD, et al. Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits? Dig Liver Dis. 2000;32:518-531.
2. Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut. 2002;50:485-489.
3. Corbett M, Schlup M. Azathioprine hypersensitivity mimicking underlying inflammatory bowel disease. Intern Med J. 2001;31:366-367.
4. Mayo JM, Colmenarejo MB, Vaquerizo PJ, et al. Hypersensitivity reaction to azathioprine in a patient with ulcerative colitis. Infrequent manifestations. Inflamm Bowel Dis. 2004;10:700.
5. Cox J, Daneshmand TK, Hawkey CJ, et al. Devastating diarrhoea caused by azathioprine: management difficulty in inflammatory bowel disease. Gut. 1988;29:686-688.
6. Sinico RA, Sabadini E, Borlandelli S, et al. Azathioprine hypersensitivity: report of two cases and review of the literature. J Nephrol. 2003;16:272-276.
7. Schapira D, Lorber M, Scharf Y. Azathioprine fever. Clin Exp Rheumatol. 1991;9:93-94.
8. Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med. 1997;126:608-614.
9. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000;118:705-713.
10. Regueiro M, Mardini H. Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn's disease. J Clin Gastroenterol. 2002;35:240-244.
11. Garey KW, Streetman DS, Rainish MC. Azathioprine hypersensitivity reaction in a patient with ulcerative colitis. Ann Pharmacother. 1998;32:425-428.
12. Godeau B, Paul M, Autegarden JE, et al. Hypersensitivity to azathioprine mimicking gastroenteritis. Absence of recurrence with 6-mercaptopurine. Gastroenterol Clin Biol. 1995;19:117-119.
13. Stetter M, Schmidl M, Krapf R. Azathioprine hypersensitivity mimicking Goodpasture's syndrome. Am J Kidney Dis. 1994;23:874-877.
14. Chevrel G, Moreau T, Vial T, et al. Hypersensitivity to azathioprine can simulate an aggravation of myasthenia. Therapie. 1998;53:77-78.
15. Tumani H, George A, Nau R, et al. Myasthenic crisis caused by azathioprine-induced fever. Nervenarzt. 1997;68:336-338.
16. Watts GF, Corston R. Hypersensitivity to azathioprine in myasthenia gravis. Postgrad Med J. 1984;60:362-363.
17. Sieb JP, Milone M, Engel AG. Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission. Brain Res. 1996;712:179-189.
18. Penn AS, Low BW, Jaffe IA, et al. Drug-induced autoimmune myasthenia gravis. Ann NY Acad Sci. 1998;841:433-449.
19. Dretchen KL, Morgenroth VH III, Standaert FG, et al. Azathioprine: effects on neuromuscular transmission. Anesthesiology. 1976;45:604-609.
20. Losavio A, Muchnik S. Facilitation of spontaneous acetylcholine release induced by activation of cAMP in rat neuromuscular junctions. Life Sci. 2000;66:2543-2556.
21. Grob D, Namba T. Characteristics and mechanism of neuromuscular block in myasthenia gravis. Ann NY Acad Sci. 1976;274:143-173.
22. Hanson P, Dive A, Brucher JM, et al. Acute corticosteroid myopathy in intensive care patients. Muscle Nerve. 1997;11:1371-1380.
23. Batchelor TT, Taylor LP, Thaler HT, et al. Steroid myopathy in cancer patients. Neurology. 1997;48:1234-1238.